Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
BioXcel Therapeutics, Inc. (BTAI) had Weighted-Average Shares Outstanding (Diluted) of 14.20M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$0.10M |
|
$-30.91M |
|
$0.01M |
|
$0.09M |
|
$14.33M |
|
$-14.23M |
|
$-16.68M |
|
$-30.91M |
|
$-30.91M |
|
$-30.91M |
|
$-30.91M |
|
$-30.91M |
|
$-30.91M |
|
$-14.23M |
|
$-14.15M |
|
14.20M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
14.20M |
$-2.18 |
|
$-2.18 |
|
| Balance Sheet Financials | |
$44.40M |
|
$0.25M |
|
$0.39M |
|
$44.79M |
|
$37.80M |
|
$92.30M |
|
$95.91M |
|
$133.71M |
|
$-88.92M |
|
$-88.92M |
|
$-88.92M |
|
20.00M |
|
| Cash Flow Statement Financials | |
$-43.41M |
|
-- |
|
$50.87M |
|
$29.85M |
|
$37.32M |
|
$7.47M |
|
$2.32M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.17 |
|
-- |
|
-- |
|
27.28 |
|
-1.23 |
|
88.78% |
|
-14518.37% |
|
-14518.37% |
|
-- |
|
-31541.84% |
|
-31541.84% |
|
$-43.41M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
0.02 |
|
-- |
|
-- |
|
34.76% |
|
34.76% |
|
-69.01% |
|
-913.71% |
|
$-4.45 |
|
$-3.06 |
|
$-3.06 |
|